Anderlini, P., Saliba, R. M., Ledesma, C., Chancoco, C., Alousi, A. M., Shpall, E. J., . . . Champlin, R. E. (2011). GEMCITABINE, FLUDARABINE AND MELPHALAN AS A NOVEL REDUCED-INTENSITY CONDITIONING REGIMEN FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED AND REFRACTORY HODGKIN LYMPHOMA. Leuk Lymphoma.
Chicago-stil citatAnderlini, Paolo, et al. "GEMCITABINE, FLUDARABINE AND MELPHALAN AS A NOVEL REDUCED-INTENSITY CONDITIONING REGIMEN FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED AND REFRACTORY HODGKIN LYMPHOMA." Leuk Lymphoma 2011.
MLA-referensAnderlini, Paolo, et al. "GEMCITABINE, FLUDARABINE AND MELPHALAN AS A NOVEL REDUCED-INTENSITY CONDITIONING REGIMEN FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED AND REFRACTORY HODGKIN LYMPHOMA." Leuk Lymphoma 2011.